Long-form, data-driven studies on 1.6M+ filings across 43 markets. Comparative regulation, walk-forward backtests, profiles, market mechanics.
Everspin CEO Sanjeev Aggarwal sold into a weak tape. The cluster is real, but the sector backdrop and the stock’s run matter more.
Two insiders bought Clip Money on July 8 as the stock traded near CAD 0.16. Here is how the filings read against the tape and peers.
Artemis Gold drew a EUR 2.1m insider buy from Jeremy Langford. The gold tape is weaker, peers are under pressure, and the cluster matters.
Predilife’s chairman bought shares as biotech steadies and AI diagnostics draw capital. The filing is small, but the cluster and backdrop matter.
Quantum’s CEO sold shares after a strong quarter. Read the filing against AI storage demand, peer moves, and our cohort data.
Innovotech’s director buying cluster lands against falling Q1 revenue, a tiny market cap, and a biotech tape that still punishes small caps.
SOPHiA GENETICS insiders sold after a June offering. Here is how the cluster reads against biotech momentum, Illumina, and the tape.
Parex Resources drew a July 7 buying cluster as Brent held near USD 74 and the TSX energy tape stayed firm. Here is the honest read.
908 Devices CEO Kevin Knopp sold 222 shares under a 10b5-1 plan. Here is how that filing reads against peers, growth, and the tape.
Two senior First Trust Capital executives bought FTECX on July 7. Here is the private credit backdrop, the peer setup, and the catch.
Two insiders bought VFLEX near NAV as alternatives stay in focus. Here is what the filings say, and where the read gets thin.
Kevin Lee sold into Bicycle Therapeutics near $4.30. Against a biotech tape that is firmer than BCYC, the filing reads as tax withholding, not conviction.